Chief Physician, Professor at Southeast University, China
Dr. Niu Chunyan is a distinguished medical professional specializing in gastroenterology. She holds the titles of Doctor of Medicine, Chief Physician, Professor, and Master’s Supervisor. Dr. Niu is an active member of the Asian Pacific Association for the Study of the Liver (APASL) and serves as an expert evaluator for the Ministry of Education and several academic organizations. Additionally, she is a standing committee member of the Traditional Chinese Medicine Chronic Disease Prevention and Education Committee under the China Medical Education Association and a member of the Jiangsu Non-alcoholic Fatty Liver Disease Academic Alliance Special Committee. She also holds a part-time professorship at Wannan Medical College. Dr. Niu has contributed extensively to academia, serving on the editorial boards of multiple renowned medical journals.
Publication Profile
Orcid
Educational Background 🎓
- Doctor of Medicine (M.D.)
Professional Experience 💼
- Chief Physician and Professor in Gastroenterology
- Master’s Supervisor
- Expert in professional degree level assessment, doctoral dissertation evaluation, and CNKI evaluation database
- Part-time Professor at Wannan Medical College
- Editorial board member of:
- Clinical Hepatobiliary Journal
- World Chinese Digestive Journal
- Practical Medicine Journal
- Chinese Medical Guide
- Chinese Journal of Medical Sciences
Research Interests 🔬
- Basic and clinical research on liver diseases
- Acid-related diseases
- Functional gastrointestinal diseases
- Mechanisms and targeted therapies for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Critical gastrointestinal conditions such as pancreatitis, gastrointestinal bleeding, and liver failure
- Helicobacter pylori infection-related diseases
Awards and Honors🏆✨
- Published over 80 papers as the first author and corresponding author, including 10+ SCI papers and 8 MEDLINE-indexed papers
- Presented research at international conferences:
- 2 Digestive Disease Week (DDW) conferences (2004)
- 3 Asian Pacific Digestive Week (APDW) conferences (2012, 2017)
- Deputy editor-in-chief of an undergraduate textbook for the 12th Five-Year Plan
- Contributor to three monographs
- Principal investigator in multiple research projects:
- 1 National Natural Science Foundation project (first participant)
- 1 Ministry of Health special project
- 5 provincial and ministerial-level projects
- 3 provincial and ministerial key discipline construction projects
- 2 national multi-center research projects
- 1 national-level college student innovation and entrepreneurship training program (2013)
- Awarded the Third Prize of the Shaanxi Provincial Higher Education Science and Technology Award for research on acid-related diseases (Project Leader, Project Number 17O10)
Conclusion🌟
Dr. Niu Chunyan is a highly accomplished expert in gastroenterology, with extensive experience in clinical practice, medical research, and academic mentorship. Her contributions to the understanding and treatment of liver diseases, acid-related disorders, and critical digestive conditions have been recognized through prestigious publications, awards, and leadership roles in national and international medical communities. She continues to advance the field through her ongoing research and dedication to medical education and professional development.
Publications 📚
📌 Amitriptyline inhibits NLRP3 inflammasome activation via the ASM/CE pathway in a cell model of NAFLD
📖 Biocell, 2024
🔗 DOI: 10.32604/biocell.2024.048551
👥 Authors: Liu, Q.; Niu, C.; Zhang, Q.; Sun, S.; Chen, Y.; Shi, Y.
📌 The Absence of STING Ameliorates Non-Alcoholic Fatty Liver Disease and Reforms Gut Bacterial Community
📖 Frontiers in Immunology, 2022
🔗 DOI: 10.3389/fimmu.2022.931176
👥 Authors: Zhang, Q.; Chen, Q.; Yan, C.; Niu, C.; Zhou, J.; Liu, J.; Song, Y.; Zhou, F.; Fan, Y.; Ren, J.
📌 Application of potassium competitive acid blockers in acid-related diseases (钾离子竞争性酸阻滞剂在酸相关疾病中的应用)
📖 World Chinese Journal of Digestology, 2021
🔗 DOI: 10.11569/wcjd.v29.i8.383
👥 Authors: Niu, C.-Y.; Luo, X.-C.
📌 Effect of amitriptyline on lipid deposition and biochemical metabolism in a cell model of NAFLD (阿米替林对非酒精性脂肪性肝病细胞模型脂质沉积及生化代谢的影响)
📖 Journal of Clinical Hepatology, 2021
🔗 DOI: 10.3969/j.issn.1001-5256.2021.01.020
👥 Authors: Liu, Q.; Zhang, Q.; Wu, F.; Yan, R.; Li, R.; Wang, J.; Niu, C.
📌 Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve NAFLD
📖 Chinese Journal of Hepatology, 2021
🔗 DOI: 10.3760/cma.j.cn501113-20200427-00219
👥 Authors: Zhang, Q.; Liu, Q.; Niu, C.Y.
📌 Application prospects of GLP-1 receptor agonists in treatment of metabolic diseases (胰高血糖素样肽-1受体激动剂在代谢性疾病治疗中的应用前景)
📖 World Chinese Journal of Digestology, 2020
🔗 DOI: 10.11569/wcjd.v28.i11.393
👥 Authors: Zhang, Q.; Zhang, X.-F.; Niu, C.-Y.
📌 Bioinformatics analysis reveals novel core genes associated with NAFLD and NASH
📖 Gene, 2020
🔗 DOI: 10.1016/j.gene.2020.144549
👥 Authors: Feng, G.; Li, X.-P.; Niu, C.-Y.; Liu, M.-L.; Yan, Q.-Q.; Fan, L.-P.; Li, Y.; Zhang, K.-L.; Gao, J.; Qian, M.-R.
📌 Hepatic macrophage-targeted therapy for fatty liver disease: Opportunities and challenges (肝巨噬细胞靶向治疗脂肪性肝病及相关肝癌的机遇与挑战)
📖 Journal of Clinical Hepatology, 2020
🔗 DOI: 10.3969/j.issn.1001-5256.2020.06.045
👥 Authors: Niu, C.; Zhao, X.
📌 Influence of drinking on NAFLD (饮酒对非酒精性脂肪性肝病的影响)
📖 Journal of Clinical Hepatology, 2020
🔗 DOI: 10.3969/j.issn.1001-5256.2020.11.044
👥 Authors: Niu, C.; Zhang, Q.; Zhao, X.
📌 Reexamination of the diagnosis of fatty liver disease under the background of disease spectrum progression (疾病谱进展背景下脂肪性肝病诊断的重新审视)
📖 Journal of Clinical Hepatology, 2020
🔗 DOI: 10.3969/j.issn.1001-5256.2020.10.043
👥 Authors: Niu, C.; Liu, Q.; Luo, X.